Ultralife (ULBI) Cost of Revenue (2016 - 2025)
Ultralife has reported Cost of Revenue over the past 16 years, most recently at $36.4 million for Q4 2025.
- Quarterly results put Cost of Revenue at $36.4 million for Q4 2025, up 30254.17% from a year ago — trailing twelve months through Dec 2025 was $145.1 million (up 63.06% YoY), and the annual figure for FY2025 was $145.1 million, up 18.83%.
- Cost of Revenue for Q4 2025 was $36.4 million at Ultralife, up from $33.8 million in the prior quarter.
- Over the last five years, Cost of Revenue for ULBI hit a ceiling of $38.0 million in Q1 2025 and a floor of $120000.0 in Q4 2024.
- Median Cost of Revenue over the past 5 years was $27.0 million (2024), compared with a mean of $26.4 million.
- Biggest five-year swings in Cost of Revenue: crashed 99.64% in 2024 and later skyrocketed 30254.17% in 2025.
- Ultralife's Cost of Revenue stood at $18.5 million in 2021, then surged by 43.55% to $26.5 million in 2022, then grew by 24.99% to $33.1 million in 2023, then crashed by 99.64% to $120000.0 in 2024, then skyrocketed by 30254.17% to $36.4 million in 2025.
- The last three reported values for Cost of Revenue were $36.4 million (Q4 2025), $33.8 million (Q3 2025), and $37.0 million (Q2 2025) per Business Quant data.